Journal article
Meta-Analysis Comparing Bivalirudin Versus Heparin Monotherapy on Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention
Abstract
With femoral access, bivalirudin decreases risks of major bleeding after percutaneous coronary intervention (PCI) and provides better net clinical benefit compared to unfractionated heparin (UFH) plus planned glycoprotein IIb/IIIa inhibitors. Whether this benefit exists compared to UFH monotherapy is less clear. We performed a systematic review and meta-analysis to compare outcomes in patients undergoing transfemoral PCI with UFH or …
Authors
Bertrand OF; Jolly SS; Rao SV; Patel T; Belle L; Bernat I; Parodi G; Costerousse O; Mann T
Journal
The American Journal of Cardiology, Vol. 110, No. 4, pp. 599–606
Publisher
Elsevier
Publication Date
August 2012
DOI
10.1016/j.amjcard.2012.03.051
ISSN
0002-9149